drugset / Trial / NCT02586363

Study of Evaluation of Cavir Tab. 0.5mg With Food Effect on Pharmacokinetics and Safety

NCT02586363

Phase 1 Unknown 30 enrolled Seoul St. Mary's Hospital
RandomizedCrossoverOpen-labelBasic science

Summary

In this clinical trial, the investigator will clarify the difference in pharmacokinetics between the group single dose Cavir Tab. 0.5mg and single dose Cavir Tab. 0.5mg with high fatty meal for healthy adult volunteer. The investigators evaluate the effect of food intake on the absorption of Cavir Tab. 0.5mg.

Timeline

Start
2015-11
Primary completion
2016-03
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Entecavir Small molecule 0.5 mg

Indications

No indication recorded.